Medtronic: The Country-of-Origin Promise on a Federal Contract

In the Medtronic country of origin settlement, the company agreed to pay $4.41 million to resolve allegations that it falsely represented where medical devices sold to the federal government were made. The buyers were the Department of Veterans Affairs and the Department of Defense. The government alleged that Medtronic certified products as coming from the United States or other countries allowed under its contracts while supplying products manufactured in China and Malaysia.

The Justice Department announced the settlement on April 2, 2015. Three whistleblowers brought the case under the False Claims Act. The Defense Logistics Agency, the Defense Criminal Investigative Service and Veterans Affairs’ Office of General Counsel assisted the U.S. Attorney’s Office in Minnesota.

The Origin Promise Was Part of the Purchase

According to the Justice Department, Medtronic promised its federal buyers that the covered products would be made in the United States or other designated countries. The department described the Trade Agreements Act as generally requiring that origin for products sold to the United States.

The government alleged that the Chinese- and Malaysian-made products failed that requirement. Both countries were outside the permitted group for the sales covered by this settlement.

Veterans Affairs and Defense were buying medical products for veterans and service members, with a promise about where those products were made. The government alleged that Medtronic sold them goods from countries the contracts excluded. Suppliers meeting the origin requirement had to compete against those sales. The purchasing rule meant little if a seller could certify one origin and supply another.

Which Devices and Which Sales Periods Were Covered?

The settlement covered anchoring sleeves sold with cardiac leads, certain instruments and devices used in spine surgery, and a handheld patient assistant used with a wireless cardiac device. The covered period ran from January 1, 2007, through December 31, 2013. For the handheld patient assistant, the agreement also covered January 1 through September 30, 2014.

The anchoring sleeves secured cardiac leads to patients. The origin requirement reached a product that held another device in place, as well as instruments used in surgery.

For a device insider, that changes where the evidence may sit. Someone responsible for an accessory’s manufacturing records may know something a person familiar only with the larger device does not. We would connect the origin representation to the particular sleeve, instrument or patient assistant sold under the contract, keeping the product and its sales period together.

From the Seller’s Certification to the Federal Payment

Medtronic’s country-of-origin case concerned the seller’s promise to the federal buyer. Device insiders may be more familiar with another health care payment chain: hospitals buy implants, physicians influence product selection, and Medicare usually includes the device cost in payment for the procedure or hospital stay. In the Veterans Affairs and Defense sales at issue here, the government challenged what Medtronic said about the products it sold to those agencies.

The distinction also explains why clinical performance does not answer the origin question. A device can perform its clinical job while the seller’s account of where it was made is false. The purchasing condition still matters to the government’s decision to pay.

A 2020 paper in the Journal of Forensic and Investigative Accounting, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains the broader pattern: goods or services can actually be supplied while the seller falsely certifies compliance with a contractual requirement. The paper also identifies the importance of the representation to the government’s payment decision. The government bought medical products with a promise attached to them.

Zoll’s ECG Cables Raised the Same Origin Question

Zoll Medical Corporation agreed to a separate $400,000 civil settlement announced on May 17, 2023 over allegations involving Chinese-made ECG cables sold to the federal government as American-made. The allegations also concerned representations about replacement-cable origin. A former employee brought the whistleblower case.

What joins the cases is the product-level origin statement. Medtronic’s announcement identified sleeves, spine instruments and a patient assistant. Zoll’s case concerned cables. The origin promise reached the products used with medical equipment, including replacements. For people who know those products, a small part can carry the discrepancy that matters to the federal buyer.

What Evidence Is Needed to Prove Fraud?

We work with the insider to understand the product records, the origin promised to the buyer and the federal sale. A manufacturing employee may know where an accessory was made. Someone handling government contracts may know what the business told the agency. Our whistleblower experts bring that knowledge together with you.

The person handling a medical product may know a different part of the sale from the person handling the supplier’s country-of-origin certification.

How Much Is a Whistleblower Claim Worth?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In Medtronic’s case, the three whistleblowers brought the origin allegations through a qui tam lawsuit. The Justice Department said they would collectively receive a share of the recovered funds.

You Know the Product Behind the Promise

If you know a device’s manufacturing origin and the different account given to a federal buyer, talk with our whistleblower experts about that sale. We build the case with you and bring in medical device fraud whistleblower lawyers who understand federal purchasing contracts. We stay with you through the whole journey to build your strongest medical device whistleblower case.